Short acting beta2-agonists for recurrent wheeze in children under two years of age

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 1, 2002, Pages

  Chavasse, Richard JPG ^a   Seddon, Paul ^b   Bara, Anna ^c   McKean, Michael C ^d  

^a SM5 1AA   (United Kingdom)

^b ROYAL ALEXANDRA CHILDREN S HOSPITAL   (United Kingdom)

^c Medical Unit   (United Kingdom)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ABNORMAL RESPIRATORY SOUND; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HUMAN; INFANT; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW;

ADRENERGIC BETA-AGONISTS; HUMANS; INFANT; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RESPIRATORY SOUNDS;

EID: 0036048483     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002873     Document Type: Article

References (50)

1. Bentur L, Canny GJ, Shields MD, Kerem E, Schuh S, Reisman MD, et al. Controlled trial of nebulised albuterol in children younger than 2 years of age with acute asthma. Pediatrics 1992;89(1):133-7.
2. Chavasse RJ, Bastian-Lee Y, Richter H, Hilliard T, Seddon P. Inhaled salbutamol for wheezy infants: A randomised controlled trial. Archives of Disease in Childhood 2000;82:370-5.
3. Clarke JR, Aston H, Silverman M. Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness. Archives of Disease in Childhood 1993;69:125-9.
4. Fox GF, Marsh MJ, Milner AD. Treatment of recurrent acute wheezing episodes in infancy with oral salbutamol and prednisolone. European Journal of Pediatrics 1996;155:512-6.
5. Kraemer R, Frey U, Sommer W, Russi E. Short-term effect on albuterol, delivered via a new auxilliary device, in wheezy infants. American Review of Respiratory Disease 1991;144:347-51.
6. Kraemer R, Graf Bigler U, Casaulta Aebischer C, Weder M, Birrer P. Clinical and physiological improvement after inhalation of low-dose beclomethasone dipripionate and salbutamol in wheezy infants. Respiration 1997;64:342-9.
7. Prahl P, Petersen NT, Hornsleth A. Beta2-agonists for the treatment of wheezy bronchitis. Annals of Allergy 1986;57:439-41.
8. Prendiville A, Green S, Silverman M. Airway responsiveness in wheezy infants: evidence for functional B adrenergic receptors. Thorax 1987;42:100-4.
9. Bentur L, Kerem E, Canny G, Reisman J, Schuh S, Stein R, et al. Response of acute asthma to beta2 agonist in children less than two years of age. Annals of Allergy 1990;65:122-6.
10. Bremont F, Moisan V, Dutau G. Continuous subcutaneous infusion of B2-agonists in infantile asthma. Pediatric Pulmonology 1992;12:81-3.
11. Closa RM, Ceballos JM, Gomez-Papi A, Galiana AS, Gutierrez C, Marti-Henneber C. Efficacy of bronchodilators administered by nebulizers versus spacer devices in infants with acute wheezing. Pediatric Pulmonology 1998;26:344-8.
12. Connor WT, Dolovich MB, Frame RA, Newhouse MT. Reliable salbutamol administration in 6- to 36-month-old children by means of a metered dose inhaler and aerochamber with mask. Pediatric Pulmonology 1989;6:263-7.
13. Daugbjerg P, Brenoe E, Forchammer H, Glazowski MJ, Kaas Ibsen K, Knabe N, et al. A comparison between nebulised terbutaline, nebulised corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 months of age. Acta Paediatrica 1993;82:547-51.
14. De La Luz Valencia Chavez M, Manotas R. Inhaled versus nebulised salbutamol in the management of acute asthma exacerbation in preschool children. A randomised controlled trial [Salbutamol inhalado o nebulizado en el tratamiento de la exacerbacion aguda del asma en el preescolar. Estudio comparativo aleatorizado]. Iateria 1999;12(3):130-4.
15. Hayden MJ, Petak F, Hantos Z, Hall G, Sly PD. Using low-frequency oscillation to detect bronchodilator responsiveness in infants. American Journal of Respiratory and Critical Care Medicine 1998;157:574-579.
16. Hayden MJ, Wildhaber JH, LeSouef PN. Bronchodilator responsiveness testing using raised volume forced expiration in recurrently wheezing infants. Pediatric Pulmonology 1998;26:35-41.
17. Henderson AJW, Young S, Stick SM, Landau LI, Lesouef PN. Effect of salbutamol on histamine induced bronchoconstriction in healthy infants. Thorax 1993;48:317-23.
18. Hickey RW, Gochman RF, Chande V, Davis HW. Albuterol delivered via metered-dose inhaler with spacer for outpatient treatment of young children with wheezing. Arichives of Pediatrics and Adolescent Medicine 1994;148:189-94.
19. Holmgren D, Bjure J, Engstrom I, Sixt R, Sten G, Wennergren G. Transcutaneous blood gas monitoring during salbutamol inhalations in young children with acute asthmatic symptoms. Pediatric Pulmonology 1992;14:75-9.
20. Jackson AC, Tennhoff W, Kraemer R, Frey U. Airway and tissue resistance in wheezy infants: Effects of albuterol. American Journal of Respiratory and Critical Care Medicine 1999;160:557-63.
21. Lenney W, Milner AD. At what age do bronchodilator drugs work?. Archives of Disease in Childhood 1978;53:532-5.
22. Mallol J, Barrueto L, Girardi G, Toro O. Bronchodilator effect of fenoterol and ipratropium bromide in infants with acute wheezing: Use of MDI with a spacer device. Pediatric Pulmonology 1987;3:352-6.
23. Mallol J, Barrueto L, Girardi G, Munoz R, Puppo H, Ulloa V, et al. Use of nebulised bronchodilators in infants: analysis of four forms of therapy. Pediatric Pulmonology 1987;3:298-303.
24. Naspitz CK, Sole D. Treatment of acute wheezing and dyspnea attacks in children under 2 years old: Inhalation of fenoterol plus ipratropium bromide versus fenoterol. Journal of Asthma 1992;29(4):253-8.
25. O'Callaghan C, Milner AD, Swarbrick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. The Lancet 1986;2(8521-2):1424-5.
26. O'Callaghan C, Milner AD, Swarbrick A. Nebulised salbutamol does have a protective effect on airways in children under 1 year old. Archives of Disease in Childhood 1988;63:479-83.
27. Orlowski L, Zychowicz C, Migdal M, Gutkowski P. Effect of salbutamol on specific airway resistance in infants with a history of wheezing. Pediatric Pulmonology 1991;10:191-4.
28. Ploin D, Chapuis FR, Stamm D, Robert J, David L, Chatelain PG, et al. High-dose albuterol by metered dose inhaler plus a spacer device versus nebulization in preschool children with recurrent wheezing: A double-blind randomized equivalence trial. Pediatrics 2000;106(2):311-7.
29. Prendiville A, Green S, Silverman M. Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax 1987;42:86-91.
30. Prendiville A, Rose A, Maxwell DL, Silverman M. Hypoxaemia in wheezy infants after bronchodilator treatment. Archives of Disease in Childhood 1987;62:997-1000.
31. Radford M. Effect of salbutamol in infants with wheezy bronchitis. Archives of Disease in Childhood 1975;50:535-8.
32. Rubilar L, Castro-Rodriguez JA, Girardi G. Randomised trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age. Pediatric Pulmonology 2000;29:264-9.
33. Rutter N, Milner AD, Hillier EJ. Effect of bronchodilators on respiratory resistance in infants and young children with bronchiolitis and wheezy bronchitis. Archives of Disease in Childhood 1975;50:719-22.
34. Sweich PJ, Hurt TL, Walkley EI, Mullen N, Archibald LF. The use of nebulised albuterol in wheezing infants. Pediatric Emergency Care 1992;8(4):184-8.
35. Seidenberg J, Mir Y, von der Hardt H. Hypoxaemia after nebulised salbutamol in wheezy infants: The importance of aerosol acidity. Archives of Disease in Childhood 1991;66:672-5.
36. Spier S, Lapierre JG, Lamarre A. Response to salbutamol during a 1st or 2nd episode of wheezing in infancy. American Review of Respiratory Disease 1985;101:A259.
37. Tal A, Baviliski C, Yohai D, Bearman JE, Gorodischer R, Moses SW. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics 1983;71(1):13-8.
38. British Thoracic Society. Asthma in children under five years of age. Thorax 1997;52 Suppl (1):9-10,18-21.
39. Chavasse R, Bastian-Lee Y, Seddon P. Preferences of bronchodilator to treat infant wheeze: A regional survey. European Respiratory Journal. 1999; Vol. 14 Suppl (30):178.
40. Clough J. Bronchodilators in infancy. Thorax 1993;48(4):308.
41. Everard M, Kurian M. Anti-cholinergic drugs for wheeze in children under the age of two years (Cochrane review). Cochrane Database of Systematic Reviews 1999, Issue 2.
42. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomised controlled trials: Is blinding necessary?. Controlled Clinical Trials 1995;17(1):1-12.
43. Kellner JD, Ohlsson A, Gadomski AM, Wang EEL. Bronchodilators for bronchiolitis (Cochrane review). The Cochrane Library 1999, Issue 2.
44. Martinez FD, Wright AL, Taussig L, Holberg CJ, Halonen M, Morgan W. Asthma and wheezing in the first six years of life. New England Journal of Medicine 1995;332(3):133-8.
45. Anonymous. Guidelines for the diagnosis and management of asthma. Expert Panel Report 2. NIH Publication 97-4051 1997.
46. Pavon D, Castro-Rodriguez JA, Rubilar L, Girardi G. Relation between pulse oximetry and clinical score in children with acute wheezing less than 24 months of age. Pediatric Pulmonology 1999;27:423-7.
47. Silverman M, Wilson N. Wheezing disorders in infancy. In: Silverman M editor(s). Childhood asthma and other wheezing disorders. 1. London: Chapman & Hall Medical, 1995:375-400. [ISBN 0-412-56900-0]
48. Strachan DP. Epidemiology. Childhood asthma and other wheezing disorders. 1. London: Chapman & Hall, 1995:7-31. [ISBN 0 412 56900 0]
49. Tager IB, Hanrahan JP, Tosteson TD. Lung function, pre- and postnatal smoke exposure, and wheezing in the first year of life. American Review of Respiratory Disease 1993;147:811-7.
50. Yung M, South M, Byrt T. Evaluation of an asthma severity score. Journal of Pediatrics and Child Health 1996;32:261-4.